Genetic Analysis AS

Genetic Analysis AS (GA) is positioned to become a world leader within the field of molecular in-vitro diagnostics of diseases related to gut imbalances. Based on the patented DNA-based GA-map platform technology, profiles of patients gut microbiota is quickly generated and can be related to various health conditions. Our first product, the GA-map Dysbiosis Test helps Gastroenterologists to measure and monitor gut microbiota status in patients with Irritable Bowel Syndrome (IBS). This is the first dysbiosis test which is commercially available, standardised, CE-marked and clinically validated (50 clinical trials + 30 publications). Further clinical applications for the tests are in...

Gut imbalance,ibd,microbiota,dna,dysbiosis,ibs,fecal analysis,gut,biotechnology,gastroenterology,gastrointestinal disorders,virus,bacteria,and clinics

Genetic analysis as operates in the Biotechnology research industry.

Genetic analysis as's revenue is 11m - 100m

Genetic analysis as has 11 - 50 employees.